Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.700
-0.150 (-5.26%)
At close: Jul 11, 2025, 4:00 PM
2.730
+0.030 (1.11%)
After-hours: Jul 11, 2025, 6:58 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $373.36 million as of July 11, 2025. Its market cap has increased by 156.00% in one year.
Market Cap
373.36M
Enterprise Value
267.11M
1-Year Change
156.00%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $373.36M, a decrease of -14.24%. That is a compound annual growth rate of -3.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 11, 2025 | 373.36M | 87.15% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 714.71B |
| Johnson & Johnson | 379.73B |
| AbbVie | 347.06B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.73B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.77B |
| AstraZeneca | 218.25B |